A citation-based method for searching scientific literature

Anthony L McCall, Daniel J Cox, Robert Brodows, John Crean, Don Johns, Boris Kovatchev. Diabetes Technol Ther 2009
Times Cited: 34







List of co-cited articles
223 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
26

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
693
23

Glucose variability; does it matter?
Sarah E Siegelaar, Frits Holleman, Joost B L Hoekstra, J Hans DeVries. Endocr Rev 2010
271
23


Evaluation of a new measure of blood glucose variability in diabetes.
Boris P Kovatchev, Erik Otto, Daniel Cox, Linda Gonder-Frederick, William Clarke. Diabetes Care 2006
214
23

Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
823
20

Exenatide improves glycemic variability assessed by continuous glucose monitoring in subjects with type 2 diabetes.
Concetta Irace, Raffaella Fiorentino, Claudio Carallo, Faustina Scavelli, Agostino Gnasso. Diabetes Technol Ther 2011
19
36

Symmetrization of the blood glucose measurement scale and its applications.
B P Kovatchev, D J Cox, L A Gonder-Frederick, W Clarke. Diabetes Care 1997
158
17

Intensive insulin therapy in critically ill patients.
G van den Berghe, P Wouters, F Weekers, C Verwaest, F Bruyninckx, M Schetz, D Vlasselaers, P Ferdinande, P Lauwers, R Bouillon. N Engl J Med 2001
17



Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index.
B P Kovatchev, D J Cox, L A Gonder-Frederick, D Young-Hyman, D Schlundt, W Clarke. Diabetes Care 1998
216
17

Glucose variability.
F John Service. Diabetes 2013
117
17

Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.
Boris P Kovatchev, William L Clarke, Marc Breton, Kenneth Brayman, Anthony McCall. Diabetes Technol Ther 2005
118
14


A novel approach to continuous glucose analysis utilizing glycemic variation.
C M McDonnell, S M Donath, S I Vidmar, G A Werther, F J Cameron. Diabetes Technol Ther 2005
214
14



Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.
Edmond A Ryan, Tami Shandro, Kristy Green, Breay W Paty, Peter A Senior, David Bigam, A M James Shapiro, Marie-Christine Vantyghem. Diabetes 2004
203
14

Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy.
L Monnier, C Colette, E Mas, F Michel, J P Cristol, C Boegner, D R Owens. Diabetologia 2010
100
14

Glycemic variability: should we and can we prevent it?
Louis Monnier, Claude Colette. Diabetes Care 2008
148
14

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Robert J Heine, Luc F Van Gaal, Don Johns, Michael J Mihm, Mario H Widel, Robert G Brodows. Ann Intern Med 2005
600
14

One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
Mathijs C Bunck, Michaela Diamant, Anja Cornér, Bjorn Eliasson, Jaret L Malloy, Rimma M Shaginian, Wei Deng, David M Kendall, Marja-Riitta Taskinen, Ulf Smith,[...]. Diabetes Care 2009
303
14

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.
Ralph A DeFronzo, Robert E Ratner, Jenny Han, Dennis D Kim, Mark S Fineman, Alain D Baron. Diabetes Care 2005
14

Glucose variability is associated with intensive care unit mortality.
Jeroen Hermanides, Titia M Vriesendorp, Robert J Bosman, Durk F Zandstra, Joost B Hoekstra, J Hans Devries. Crit Care Med 2010
277
14

Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
B Guerci, L Monnier, P Serusclat, C Petit, P Valensi, D Huet, D Raccah, C Colette, S Quéré, S Dejager. Diabetes Metab 2012
53
14

Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring.
David Rodbard, Timothy Bailey, Lois Jovanovic, Howard Zisser, Roy Kaplan, Satish K Garg. Diabetes Technol Ther 2009
95
14



Variability of blood glucose concentration and short-term mortality in critically ill patients.
Moritoki Egi, Rinaldo Bellomo, Edward Stachowski, Craig J French, Graeme Hart. Anesthesiology 2006
538
11

Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.
I M E Wentholt, W Kulik, R P J Michels, J B L Hoekstra, J H DeVries. Diabetologia 2008
139
11

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.
John M Lachin, Saul Genuth, David M Nathan, Bernard Zinman, Brandy N Rutledge. Diabetes 2008
278
11

THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.
J SCHLICHTKRULL, O MUNCK, M JERSILD. Acta Med Scand 1965
375
11


Intensive versus conventional glucose control in critically ill patients.
Simon Finfer, Dean R Chittock, Steve Yu-Shuo Su, Deborah Blair, Denise Foster, Vinay Dhingra, Rinaldo Bellomo, Deborah Cook, Peter Dodek, William R Henderson,[...]. N Engl J Med 2009
11

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.
David C Klonoff, John B Buse, Loretta L Nielsen, Xuesong Guan, Christopher L Bowlus, John H Holcombe, Matthew E Wintle, David G Maggs. Curr Med Res Opin 2008
547
11

Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
John B Buse, Richard M Bergenstal, Leonard C Glass, Cory R Heilmann, Michelle S Lewis, Anita Y M Kwan, Byron J Hoogwerf, Julio Rosenstock. Ann Intern Med 2011
389
11



Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
11

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
11

The challenges of measuring glycemic variability.
David Rodbard. J Diabetes Sci Technol 2012
53
11

Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data.
Boris P Kovatchev, Daniel J Cox, Anand Kumar, Linda Gonder-Frederick, William L Clarke. Diabetes Technol Ther 2003
79
11



A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus.
Anthony L McCall, Daniel J Cox, John Crean, Maury Gloster, Boris P Kovatchev. Diabetes Technol Ther 2006
56
8

Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells.
A Takeuchi, D C Throckmorton, A P Brogden, N Yoshizawa, H Rasmussen, M Kashgarian. Am J Physiol 1995
59
8


Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data.
D J Cox, B P Kovatchev, D M Julian, L A Gonder-Frederick, W H Polonsky, D G Schlundt, W L Clarke. J Clin Endocrinol Metab 1994
101
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.